iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy (vol 20, 361, 2019)

Autor: de Jong, W, Aerts, J, Allard, S, Brander, C, Buyze, J, Florence, E, van Gorp, E, Vanham, G, Leal, L, Mothe, B, Thielemans, K, Plana, M, Garcia, F, Gruters, R
Rok vydání: 2019
Zdroj: Trials
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ISSN: 1745-6215
Popis: Following publication of the original article [1], we have been notified that end note would need to be adjusted.
Databáze: OpenAIRE
Externí odkaz: